130 related articles for article (PubMed ID: 12643739)
1. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
Liu Y; Chen Z; He N
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
Wakita T; Moradpour D; Tokushihge K; Wands JR
J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
[TBL] [Abstract][Full Text] [Related]
5. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
[TBL] [Abstract][Full Text] [Related]
7. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
8. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.
Alt M; Eisenhardt S; Serwe M; Renz R; Engels JW; Caselmann WH
Eur J Clin Invest; 1999 Oct; 29(10):868-76. PubMed ID: 10583429
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus-transfected cholangiocarcinoma by antisense oligodeoxynucleotide in nude mice.
Liu XF; Zhou XT; Zou SQ
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):115-9. PubMed ID: 14969852
[TBL] [Abstract][Full Text] [Related]
10. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro.
Ren Y; Wei D; Zhan X
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):137-43. PubMed ID: 15202936
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
15. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
[TBL] [Abstract][Full Text] [Related]
16. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
18. RNAi expression mediated inhibition of HCV replication.
Hamazaki H; Ujino S; Abe E; Miyano-Kurosaki N; Shimotohno K; Takaku H
Nucleic Acids Symp Ser (Oxf); 2004; (48):307-8. PubMed ID: 17150601
[TBL] [Abstract][Full Text] [Related]
19. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
[TBL] [Abstract][Full Text] [Related]
20. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.
Alt M; Renz R; Hofschneider PH; Caselmann WH
Arch Virol; 1997; 142(3):589-99. PubMed ID: 9349305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
